Health Care·Biotechnology·$5.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.98 | N/A | -55.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.98 | N/A | -55.56% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management conveyed a cautious outlook, recognizing the difficulties in meeting expectations. They reiterated their commitment to navigating through these challenges.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term strategies despite current setbacks.
The earnings report indicates that Scholar Rock is struggling to meet expectations, particularly reflected in the significant EPS miss. The stock dropped 6.4% in response, suggesting investor concern over the company's current performance and future prospects. Without any revenue figures or guidance updates, uncertainty remains about the company's direction moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Aug 4, 2025